openPR Logo
Press release

Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market to Exhibit a Remarkable CAGR of 9.10% by 2030, Size, Share, Trends, Key Drivers, Demand, Opportunity Analysis and Competitive Outlook

Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market

Data Bridge Market Research analyses that the global non-peptide drugs of angiotensin II receptor antagonist market, which was USD 177,430.32million in 2022, is expected to reach USD 325,986.34 million by 2030, and is expected to undergo a CAGR of 9.10% during the forecast period 2023-2030.

Non-peptide drugs of Angiotensin II receptor antagonists (also known as Angiotensin II receptor blockers or ARBs) are a class of medications used to treat conditions like hypertension (high blood pressure) and certain cardiovascular conditions. They work by blocking the action of angiotensin II, a hormone that narrows blood vessels and raises blood pressure. By doing so, ARBs help relax blood vessels, lower blood pressure, and reduce the workload on the heart.

Browse More About This Research Report @
https://www.databridgemarketresearch.com/reports/global-non-peptide-drugs-of-angiotensin-ii-receptor-antagonist-market

Some of the major players operating in the Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market are Novartis (Switzerland), Daiichi Sankyo (Japan), Takeda Pharmaceutical Company (Japan), Boehringer Ingelheim  (Germany), AstraZeneca (U.K.), Pfizer (U.S.), Sanofi (France), Merck & Co. (U.S.), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), GlaxoSmithKline (GSK) (United Kingdom), Bayer (Germany), Mylan (United States), Sun Pharmaceutical Industries (India), Torrent Pharmaceuticals (India), Zydus Cadila (India), Cipla  (India), Glenmark Pharmaceuticals (India), Mitsubishi Tanabe Pharma (Japan), Ipca Laboratories (India) among others.

Competitive Landscape and Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Share Analysis :

Global non-peptide drugs of angiotensin II receptor antagonist market competitive landscape provide details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global non-peptide drugs of angiotensin II receptor antagonist market.

Browse Trending Reports:

https://dbmrblogs.blogspot.com/2024/07/homeopathy-products-market-trends.html

https://dbmrblogs.blogspot.com/2024/08/dna-fragmentation-technique-market-size.html

https://dbmrblogs.blogspot.com/2024/08/endotoxin-detecting-reagents-market.html

https://dbmrblogs.blogspot.com/2024/08/fiberglass-fabric-market-industry.html

About Data Bridge Market Research:

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Contact Us: -
Data Bridge Market Research
Email: - sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market to Exhibit a Remarkable CAGR of 9.10% by 2030, Size, Share, Trends, Key Drivers, Demand, Opportunity Analysis and Competitive Outlook here

News-ID: 3648310 • Views:

More Releases from Data Bridge Market Research

Acoustic Emission Testing Market: Comprehensive Insights
Acoustic Emission Testing Market: Comprehensive Insights
Acoustic emission testing (AET) is a crucial non-destructive testing method that plays a significant role in monitoring the structural integrity of materials and structures. By capturing and analyzing the sound waves emitted from a material under stress, AET provides valuable information about potential faults or failures. This guest post delves into the Acoustic Emission Testing (AET) market, exploring its size, opportunities, share, demand, trends, and growth. Introduction Acoustic emission testing is a
The Vitamin, Mineral, and Supplements Market: An In-Depth Analysis
The Vitamin, Mineral, and Supplements Market: An In-Depth Analysis
The Vitamin, Mineral, and Supplements (VMS) market is a dynamic and ever-evolving sector within the health and wellness industry. With increasing consumer awareness about health and nutrition, this market has witnessed significant growth and transformation over the past few years. This guest post provides a comprehensive overview of the VMS market, exploring its size, opportunities, share, demand, trends, and growth prospects. Introduction The VMS market encompasses a wide range of products designed
Self-Checkout Systems Market is expected to reach USD 7.43 Billion by 2030 and is expected to undergo a CAGR of 8.37%
Self-Checkout Systems Market is expected to reach USD 7.43 Billion by 2030 and i …
Self-Checkout Systems Market Segmentation: Identifying Core Segments Global Self-Checkout Systems Market, By Offering (Hardware, Software, Services), Model Type (Cash, Cashless), Mounting Type (Stand-Alone, Wall-Mounted and Countertop), End User (Supermarkets, Hypermarkets and Department Stores, Convenience Stores, Others), Organization Size (Small and Medium Sized Enterprises and Large Enterprises), Application (Retail, Financial Services, Entertainment, Travel, Healthcare and Others) - Industry Trends and Forecast to 2030. Self-Checkout Systems Market CAGR Estimation Data Bridge Market Research analyses that
Predictive Maintenance Market is expected to reach USD 36.01 Billion by 2029 and is expected to undergo a CAGR of 32.30%
Predictive Maintenance Market is expected to reach USD 36.01 Billion by 2029 and …
Predictive Maintenance Market Segmentation: Identifying Core Segments Global Predictive Maintenance Market, By Components (Solution, Services), Deployment Mode (Cloud, On-Premise), Organisation Size (Large Enterprises, Small and Medium-Sized Enterprises), Vertical (Manufacturing, Energy and Utilities, Transportation, Government, Healthcare, Aerospace and Defense, Others), Stakeholder (MRO, OEM/ODM, Technology Integrators) - Industry Trends and Forecast to 2029 Predictive Maintenance Market CAGR Estimation Data Bridge Market Research analyses that the Global Predictive Maintenance Market which was USD 3.84 Million in

All 5 Releases


More Releases for Angiotensin

Angiotensin Receptor Blockers (ARBs) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Angiotensin Receptor Blockers (ARBs) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report
Angiotensin II Receptor Blocker (ARBs) API Market To Upscale Amidst Technologica …
The professional intelligence report presents a comprehensive evaluation of various factors that may influence the future performance of the Global Angiotensin II Receptor Blocker (ARBs) API Market during the forecast period of 2021 to 2027. It highlights a host of interlinked factors that may create promising growth opportunities in the global Angiotensin II Receptor Blocker (ARBs) API market in coming years. It also provides holistic perspective regarding different trends that
Angiotensin Modulators Market 2020 Clinical Survey Report to 2026
Angiotensin Modulators -Pipeline Insight, 2020 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Angiotensin Modulators Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has
Angiotensin Receptor Antagonists Market: The 2020-2030 Market and Growth Factor …
The study of Angiotensin Receptor Antagonists Market published by Prophecy Market Insights offerings all compilation of the historical, current and future outlook of the market. This report is very helpful for understanding the market complexity. This report will help manufacturers, distributors, and retailers to realize and understand the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue etc.
Type 2 Angiotensin II Receptor Global Market Research Report 2025
Type 2 Angiotensin II Receptor Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/type-2-angiotensin-ii-receptor-market/80995 The report firstly introduced the Type 2 Angiotensin II
Angiotensin Converting Enzyme Inhibitors Market to Develop Rapidly by 2025
Angiotensin converting enzyme inhibitors are a group of drugs used for the treatment of heart failure, high blood pressure (hypertension), or decrease complications of myocardial infarction (heart attack). These drugs are also useful in slowing down kidney disease progression in patients with chronic kidney disease or kidney disease in diabetic patients. The mechanism of action of angiotensin converting enzyme inhibitors is to decrease the amount of angiotensin II produced. Angiotensin